The use or generation of biomedical data and existing medicines to discover and establish new treatments for patients with rare diseases – recommendations of the IRDiRC Data Mining and Repurposing Task Force

The number of available therapies for rare diseases remains low, as fewer than 6% of rare diseases have an approved treatment option. The International Rare Diseases Research Consortium (IRDiRC) set up the mul...

Source: Orphanet Journal of Rare Diseases - October 15, 2019 Category: Internal Medicine Authors: Noel T Southall, Madhusudan Natarajan, Lilian Pek Lian Lau, Anneliene Hechtelt Jonker, Beno ît Deprez, Tim Guilliams, Lawrence Hunter, Carin MA Rademaker, Virginie Hivert and Diego Ardigò Tags: Position statement Source Type: research